The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:
ADVERTISEMENT

Opinion

View All

Christmas celebrations in Bethlehem muted amid ongoing Israel-Hamas war

“Bethlehem is the capital of Christmas. It’s supposed to be the best time of the year. None of that i...

BREAKING: 38 dead after jet crashes in Kazakhstan—passenger films crash from inside cabin as plane goes down

Azerbaijan Airlines flight J2-8243 was on its way to Grozny in Russia but was diverted because of fog...

Massive Russian strike leaves over half a million Ukrainians without heat on Christmas: report

“Unfortunately, we will have to evacuate one of the city’s hospitals again, where more than a hundred...

LIBBY EMMONS: What to do when your kid demands to know the truth about Santa Claus

"Please, just tell me if Santa is real, I have to know the truth!"...